Edwards Lifesciences Return on Investment 2010-2022 | EW

Current and historical return on investment (ROI) values for Edwards Lifesciences (EW) over the last 10 years.
Edwards Lifesciences ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-09-30 $1.68B $6.81B 25.55%
2022-06-30 $1.66B $6.54B 26.04%
2022-03-31 $1.75B $6.44B 28.21%
2021-12-31 $1.69B $6.43B 28.70%
2021-09-30 $1.67B $6.14B 29.92%
2021-06-30 $1.64B $5.73B 31.21%
2021-03-31 $0.92B $5.25B 18.78%
2020-12-31 $0.90B $5.17B 18.98%
2020-09-30 $0.86B $4.81B 18.55%
2020-06-30 $0.79B $4.43B 17.54%
2020-03-31 $1.23B $4.50B 27.75%
2019-12-31 $1.15B $4.74B 26.54%
2019-09-30 $0.83B $4.41B 20.42%
2019-06-30 $0.79B $4.09B 19.87%
2019-03-31 $0.77B $4.04B 19.89%
2018-12-31 $0.75B $3.73B 19.78%
2018-09-30 $1.06B $3.96B 28.60%
2018-06-30 $1.04B $3.76B 27.58%
2018-03-31 $1.04B $3.70B 27.15%
2017-12-31 $1.09B $3.40B 28.83%
2017-09-30 $0.96B $4.20B 25.21%
2017-06-30 $0.92B $3.96B 25.88%
2017-03-31 $0.89B $3.59B 26.57%
2016-12-31 $0.78B $3.44B 24.64%
2016-09-30 $0.79B $3.29B 25.45%
2016-06-30 $0.75B $3.07B 24.72%
2016-03-31 $0.68B $2.90B 22.82%
2015-12-31 $0.64B $3.10B 21.74%
2015-09-30 $0.62B $3.03B 21.45%
2015-06-30 $0.59B $2.89B 21.26%
2015-03-31 $0.56B $2.82B 20.97%
2014-12-31 $0.49B $2.79B 19.70%
2014-09-30 $0.47B $2.64B 20.13%
2014-06-30 $0.45B $2.51B 20.58%
2014-03-31 $0.46B $2.07B 22.80%
2013-12-31 $0.47B $2.14B 24.57%
2013-09-30 $0.49B $1.97B 26.99%
2013-06-30 $0.48B $1.81B 27.36%
2013-03-31 $0.45B $1.79B 26.29%
2012-12-31 $0.42B $1.67B 25.57%
2012-09-30 $0.36B $1.71B 22.79%
2012-06-30 $0.33B $1.62B 21.20%
2012-03-31 $0.31B $1.57B 20.04%
2011-12-31 $0.30B $1.49B 26.21%
2011-09-30 $0.29B $1.53B 38.06%
2011-06-30 $0.30B $1.56B 77.18%
2011-03-31 $0.30B 92.66%
2010-12-31 $0.29B 44.25%
2010-09-30 $0.27B 28.14%
2010-06-30 $0.26B $1.30B 20.65%
2010-03-31 $0.25B $1.28B 20.50%
2009-12-31 $0.24B $1.25B 20.67%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $47.328B $5.233B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00